The monocyte activation test (MAT) was included in the European Pharmacopoeia (Ph Eur) in 2010. It is to detect substances that may have fever-inducing effects on humans.
Labor LS offers the monocyte activation test as an important complement to the LAL and pyrogen test because it detects not only endotoxins and has a similarly high sensitivity. On this basis, a broader range of preparations can be investigated than with the traditional pyrogen test. However, a product-specific development and validation is a prerequisite for the application of the test.
Press release dated 23 April 2018
Mangelsfeld 4, 5, 6
97708 Bad Bocklet-
Fon: +49 (0)9708/9100-0
Fax: +49 (0)9708/9100-36
In our Infobox, we make additional information on our company, our service portfolio and our QM certification available to you in a download.